Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | NFKBIA | P25963 | 2/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | FASN | P49327 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3644476 | 0.84 | TSHR (0.62) | ALDH1A1NFKBIARELASLC40A1KMT2A | |
| SCHEMBL3837982 | 0.83 | NFKBIA (0.60) | CYP2C9ALDH1A1NFKBIARELASLC40A1 | |
| SCHEMBL11272841 | 0.82 | NFKBIA (0.48) | NPSR1MAPTCYP2C9ALDH1A1NFKBIA | |
| SCHEMBL10888517 | 0.82 | NFKBIA (0.58) | CYP2C9ALDH1A1NFKBIARELASLC40A1 | |
| SCHEMBL21753211 | 0.79 | NPSR1 (1.00) | NPSR1MAPTCYP2C9ALDH1A1MAPK1 | |
| SCHEMBL6557188 | 0.79 | SLC40A1 (0.48) | NPSR1MAPTCYP2C9ALDH1A1NFKBIA | |
| SCHEMBL11269034 | 0.78 | SLC40A1 (0.49) | CYP2C9ALDH1A1NFKBIARELASLC40A1 | |
| Sulfamerazine SCHEMBL29538415 | 0.77 | MAPT (1.00) | NPSR1MAPTCYP2C9ALDH1A1MAPK1 | |
| Sulfamerazine SCHEMBL33999 | 0.77 | MAPT (1.00) | NPSR1MAPTCYP2C9ALDH1A1MAPK1 | |
| Sulfamerazine SCHEMBL93591 | 0.75 | MAPT (0.97) | NPSR1MAPTCYP2C9ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6099864-A | In situ activation of microcapsules | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2000-08-08 | — | — | US | claimed |
| WO-1999059554-A1 | IN SITU ACTIVATION OF MICROCAPSULES | NASA/JOHNSON SPACE CENTER (US) | 1999-11-25 | — | — | WO | claimed |
| US-4315931-A | MICROBIOCIDES, INFECTIOUS DISEASES | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| EP-4125840-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES | Som Innovation Biotech, S.A. (ES) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021191417-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES | SOM INNOVATION BIOTECH, S.A. (ES) | 2021-09-30 | — | — | WO | disclosed |
| US-7766979-B2 | Controlled transformation of a solid to another solid crystalline phase by subjecting the solid to a tribochemical treatmentcomprising the transmissioon of high kinetic energies or >20 G;purifying a solvated polymorph drug to a solvent-free form byhigh kinetic energy ball milling | AVANTIUM INTERNATIONAL B.V. (NL) | 2010-08-03 | — | — | US | disclosed |
| US-20070202024-A1 | Phase transformation in molecular solids | AVANTIUM INTERNATIONAL B.V. | 2007-08-30 | — | — | US | disclosed |
| EP-1720517-A1 | PHASE TRANSFORMATION IN MOLECULAR SOLIDS | Avantium International B.V. (NL) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005072699-A1 | PHASE TRANSFORMATION IN MOLECULAR SOLIDS | AVANTIUM INTERNATIONAL B.V. (NL) | 2005-08-11 | — | — | WO | disclosed |
| US-6099864-A | In situ activation of microcapsules | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2000-08-08 | — | — | US | disclosed |
| WO-1999059554-A1 | IN SITU ACTIVATION OF MICROCAPSULES | NASA/JOHNSON SPACE CENTER (US) | 1999-11-25 | — | — | WO | disclosed |
| US-4333936-A | Novel amidino-benzylpyrimidines, processes for their manufacture and antibacterial and antiprotozoal use thereof | BASF AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | disclosed |
| US-4315931-A | MICROBIOCIDES, INFECTIOUS DISEASES | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | disclosed |
| EP-0043055-A1 | Combinations of therapeutically active substances, process for their manufacture and their use and means containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-01-06 | — | — | EP | disclosed |
| EP-0000335-B1 | ESTERS OF N-PYRIMIDINYL-CARBOXIMIDIC ACID, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM. | BASF Aktiengesellschaft (DE) | 1981-10-07 | — | — | EP | disclosed |
| EP-0000336-B1 | N-BENZYLPYRIMIDINYL-AMIDINES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1981-04-15 | — | — | EP | disclosed |
| EP-0000336-A1 | N-benzylpyrimidinyl-amidines, process for their preparation and medicines containing them | BASF Aktiengesellschaft (DE) | 1979-01-24 | — | — | EP | disclosed |
| US-4011332-A | RODENTICIDE | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) | 1977-03-08 | — | — | US | disclosed |